CAMBRIDGE, Mass. – Cellino Biotech, Inc., a biotechnology company advancing autonomous, closed biomanufacturing for personalized regenerative medicines, today announced the appointment of Chris Gibson ...

“This is great news as the second round of new hydrogen projects will accelerate the development of an innovative new industry creating jobs all over the country, as well as adding crucial flexibility ...

Press Release – November 26, 2024 – HOUSTON – Keener Management is pleased to announce the appointment of Sandra Kainer as Regional Vice President. With more than 20 years of experience in property ...

October 25, 2024 – LAKELAND, Fla. – Publix has been named on the 2024 Fortune’s Best Workplaces for Women list. “When we embrace diversity, we help empower our associates to reach their full potential ...

Press Release – Fri 20 Dec 2024 – Oslo, 20 December 2024: B2 Impact ASA has entered into an agreement to acquire Zolva’s portfolios in Finland, Norway and Sweden. As part of the transaction, B2 Impact ...

SAN DIEGO – National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, today announced that Dr. Susan Billings will join ...

Landmark agreement to accelerate adoption and innovation of network APIs includes a newly formed company that will drive new monetization opportunities for the industry. Today, some of the world’s ...

Meeting on the margins of the Summit of the Future at United Nations (UN) headquarters in New York, Deputy Secretary-General of the Organisation for Economic Co-operation and Development (OECD) Ulrik ...

Ericsson and Mobily collaborate on an Artificial Intelligence-powered 5G trial aimed at advancing Mobily’s network performance. Using a module from the Ericsson Cognitive Software portfolio, the trial ...

CHARLOTTESVILLE, Va. – Apex Clean Energy today announced the appointment of Kenny Chernauskas to Chief Financial Officer, expanding his responsibilities to include oversight of the company’s project ...

Adocia (Euronext Paris: FR0011184241 – ADOC, the “Company”), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions for the treatment of ...

The addition of the sales-focused role highlights the company’s commitment to diversifying its client portfolio and expanding its Migration offering NEW YORK - Align, the premier global provider of ...